Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 1c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• ZTO Express (ZTO) Tops Q2 EPS by 379c
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c